CDXI Stock Price, Chart, Stats & News

Cardax, Inc.
Save
Cardax, Inc. (CDXI) does not currently pay a dividend.
80
Market cap
–
Current P/E
–
Forward P/E
CDXI chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Cardax, Inc. is a biopharmaceutical enterprise focused on both creating and marketing nutritional supplements for maintaining inflammatory well-being, as well as developing pharmaceutical treatments for chronic ailments rooted in inflammation and oxidative stress. Its product portfolio includes ZanthoSyn, an advanced supplement for inflammation, health, and longevity that delivers astaxanthin with superior absorption and purity. This product is primarily distributed through online sales and wholesale channels.
Similar securities
Based on sector and market capitalization
Report issue





